Prot# 747-304: A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis

Project: Research project

Project Details

StatusActive
Effective start/end date4/13/182/3/22

Funding

  • INC Research, LLC (Prot#747-304)
  • Intercept Pharmaceuticals, Inc. (Prot#747-304)